Utpal Koppikar - Feb 7, 2023 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role
Chief Financial Officer
Signature
/s/ Jeff Kiekhofer, Attorney-in-Fact for Utpal Koppikar
Stock symbol
ATRA
Transactions as of
Feb 7, 2023
Transactions value $
-$13,568
Form type
4
Date filed
2/9/2023, 04:00 PM
Previous filing
Nov 18, 2022
Next filing
Feb 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRA Common Stock Sale -$13.6K -2.49K -1.3% $5.46 189K Feb 7, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations in connection with the vesting of previously granted restricted stock units.